bcbs semaglutide Blue Cross Blue Shield Drops Coverage of GLP-1 Obesity Drugs Does Blue Cross Blue Shield

That positioning is dishonest

Weve spent the last two years drawing on Nooms deep expertise in behavior change to create the ultimate GLP-1 companion program to solve the medications twin challenges, persistence and muscle-mass loss, while also driving enhanced weight loss outcomes, he details

The homepage shows news-outlet logos paired with quotes that read like generic GLP-1 commentary, but none of the logos link to actual articles

The TRIUMPH-4 Phase 3 results announced in December 2025 showed 28.7% average weight loss the highest ever recorded in a Phase 3 obesity trial, exceeding both tirzepatide's results and bariatric surgery benchmarks

Clean by standard vegan, non-GMO, gluten-free, no added sugar